Stay updated on Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Sign up to get notified when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.

Latest updates to the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page
- Check2 days agoChange DetectedThere are no additions or deletions provided in the input; the change set is empty. As a result, the page content remains unchanged according to the supplied data.SummaryDifference0.1%

- Check9 days agoChange Detected- Revision updated from v3.6.5 to v3.6.6. This is a minor metadata update and does not modify the study information or visible content.SummaryDifference0.2%

- Check16 days agoChange DetectedNo textual changes are recorded for this page in the provided data.SummaryDifference0.2%

- Check23 days agoChange DetectedNo additions or deletions were reported in the provided changes, so the page content remains unchanged. The page describes the Study Details for NCT04548791, a Phase 1/2 trial of Marzeptacog Alfa (Activated) in inherited bleeding disorders.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page's revision indicator was updated from Revision: v3.6.4 to Revision: v3.6.5, representing a software version update. This change updates the site's metadata without altering the study details or content.SummaryDifference0.1%

- Check38 days agoChange DetectedNo additions or deletions were detected; the page content remains unchanged.SummaryDifference0.2%

Stay in the know with updates to Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.